Rekl\u0101mas, m\u0101rketings un sabiedrisk\u0101s attiec\u012bbas ir jebkura liela uz\u0146\u0113muma pamat\u0101, lai populariz\u0113tu un padar\u012btu atpaz\u012bstamu ne tikai uz\u0146\u0113mumu, bet ar\u012b t\u0101 pied\u0101v\u0101tos produktus. Bet ko dar\u012bt tad, ja produktu, kuru ra\u017eo uz\u0146\u0113mums, visp\u0101r ir aizliegts reklam\u0113t?<\/p>\n\n\n\n
Pasaules pieredze r\u0101da, ka da\u017e\u0101dus pakalpojumus vai produktus ar likumu ir aizliegts reklam\u0113t. Tas ne tikai padara sare\u017e\u0123\u012bt\u0101ku uz\u0146\u0113muma produkta noieta veicin\u0101\u0161anu, bet ar\u012b rada nepiecie\u0161am\u012bbu p\u0113c da\u017e\u0101du papildu iesp\u0113ju izmanto\u0161anas komunik\u0101cijas jom\u0101. Viena no \u0161\u0101da veida prec\u0113m, kuras ir aizliegts atkl\u0101ti un tie\u0161i reklam\u0113t, ir recep\u0161u medikamenti, kas savuk\u0101rt ir pamatprodukts lielai da\u013cai farmaceitisko uz\u0146\u0113mumu.<\/p>\n\n\n\n
T\u0101 A\/S Grindeks mainoties uz\u0146\u0113muma strat\u0113\u0123ijai, nok\u013cuva gr\u016bt\u012bb\u0101s, jo p\u0101rtrauca ra\u017eot vitam\u012bnus, kurus var\u0113ja ieg\u0101d\u0101ties bez recept\u0113m. Iepriek\u0161, tos veiksm\u012bgi reklam\u0113jot, var\u0113ja piesaist\u012bt nepiecie\u0161amo m\u0113r\u0137auditoriju, ta\u010du \u0161obr\u012bd Grindeks,<\/em> v\u0113r\u0161ot uzman\u012bbu uz ilggad\u0113jo pieredzi, jaun\u0101ko tehnolo\u0123iju un produktu terapeitiskaj\u0101m grup\u0101m, piln\u012bb\u0101 piev\u0113rsies recep\u0161u medikamentu ra\u017eo\u0161anai. Veiksm\u012bg\u0101kais veids ir sabiedrisk\u0101s attiec\u012bbas, k\u0101 kompens\u0113t inform\u0101cijas iztr\u016bkumu situ\u0101cij\u0101, kad uz\u0146\u0113mumiem nav iesp\u0113jas populariz\u0113t savu pre\u010du z\u012bmi. Tie\u0161i t\u0101p\u0113c tiek izmantotas iesp\u0113jas un inform\u0101cijas kan\u0101li, ar kuru pal\u012bdz\u012bbu uzman\u012bba tiek piev\u0113rsta tie\u0161i komp\u0101nijas brendam un t\u0101 t\u0113lam, k\u0101 ar\u012b reput\u0101cijai. \u0160\u0101d\u0101 gad\u012bjum\u0101 j\u0101atz\u012bst sabiedrisko attiec\u012bbu risin\u0101jumu iesp\u0113jas. Iesaistoties soci\u0101l\u0101s atbild\u012bbas kampa\u0146\u0101s, veidojot iek\u0161\u0113jo un \u0101r\u0113jo komunik\u0101ciju ar m\u0113r\u0137auditorij\u0101m, piesaistot da\u017e\u0101da veida speci\u0101listus (kas ir tie\u0161s inform\u0101cijas kan\u0101ls), tiek nog\u0101d\u0101ta prec\u012bzi m\u0113r\u0137\u0113ta inform\u0101cija un populariz\u0113ts uz\u0146\u0113muma t\u0113ls.<\/p>\n\n\n\n Savienojot m\u0101rketinga strat\u0113\u0123iju ar veiksm\u012bgu PR<\/em>, komp\u0101nija ne tikai padara sevi paz\u012bstamu, bet ar\u012b sasniedz m\u0113r\u0137auditoriju, izmantojot sponsor\u0113\u0161anas aktivit\u0101tes, informat\u012bvos bukletus, da\u017e\u0101da veida dal\u012bbu konferenc\u0113s, izst\u0101d\u0113s un balvu pasnieg\u0161anas ceremonij\u0101s. M\u016bsu pieredze r\u0101da, ka, iesaistoties da\u017e\u0101da veida sabiedrisko attiec\u012bbu aktivit\u0101t\u0113s, uz\u0146\u0113mums sp\u0113j izveidot sev nepiecie\u0161amo reput\u0101ciju, kas \u2013 savuk\u0101rt \u2013 pal\u012bdz uztur\u0113t kvalitat\u012bvu saikni ar medijiem, un inform\u0101cijas pl\u016bsmu, nodro\u0161inot \u2013 kas ir \u0101rk\u0101rt\u012bgi svar\u012bgi \u2013 atgriezenisko saiti. Izveidojot nevainojamu inform\u0101cijas apriti un veidojot pozit\u012bvu uz\u0146\u0113muma t\u0113lu, tiek piesaist\u012bta auditorija un veiksm\u012bgi izveidota uz\u0146\u0113muma brenda atpaz\u012bstam\u012bba, kas nodro\u0161ina ar\u012b produktu un pre\u010du z\u012bmju iev\u0113ro\u0161anu. Tom\u0113r vissvar\u012bg\u0101kais ir sasniegt tie\u0161i savu m\u0113r\u0137auditoriju.<\/p>\n\n\n\n Svar\u012bg\u0101kais ir vispirms izprast \u2013 kas tie\u0161i ir m\u016bsu m\u0113r\u0137auditorija? Lai sasniegtu savus biznesa m\u0113r\u0137us, vispirms ir prec\u012bzi j\u0101defin\u0113, ko tie\u0161i m\u0113s gribam pan\u0101kt, t\u0101tad \u2013 k\u0101dus cilv\u0113kus uzrun\u0101t un k\u0101 to izdar\u012bt, ja rekl\u0101ma k\u0101 komunik\u0101ciju kan\u0101ls mums nav pieejama. Inform\u0101cijas tr\u016bkums rekl\u0101mas veid\u0101 ir lieta, kuru neap\u0161aub\u0101mi nepiecie\u0161ams kompens\u0113t ar da\u017e\u0101du citu inform\u0101cijas resursu izmanto\u0161anu, un \u0161aj\u0101 gad\u012bjum\u0101 t\u0101 ir pati farm\u0101cijas nozar\u0113 iesaist\u012bt\u0101 m\u0113r\u0137auditorija \u2013 \u0101rsti, farmaceiti, aptiek\u0101ri, k\u0101 ar\u012b da\u017e\u0101di viedok\u013ca l\u012bderi. Neskatoties uz to, ka rekl\u0101mas aizlieguma probl\u0113ma past\u0101v ar\u012b cit\u0101s nozar\u0113s, piem., alkohola vai tabakas izstr\u0101d\u0101jumu tirdzniec\u012bb\u0101, medikamenti (at\u0161\u0137ir\u012bb\u0101, piem., no azartsp\u0113l\u0113m un atkar\u012bbu izraiso\u0161\u0101m viel\u0101m) ir vit\u0101li svar\u012bgi, da\u017eos gad\u012bjumos tie \u2013 v\u0101rda tie\u0161\u0101 noz\u012bm\u0113 \u2013 var b\u016bt dz\u012bv\u012bbas un n\u0101ves jaut\u0101jums, t\u0101p\u0113c par tiem sabiedr\u012bbai noteikti ir j\u0101b\u016bt inform\u0113tai.<\/p>\n\n\n\n Farm\u0101cijas nozar\u0113 svar\u012bgi ir veidot sadarb\u012bbu starp farmaceitiem, \u0101rstiem un tirgot\u0101jiem. Lai sasniegtu \u0161o m\u0113r\u0137auditoriju, nepiecie\u0161ams izmantot ne tikai PR<\/em> metodes, bet ar\u012b tie\u0161\u0101 m\u0101rketinga formas, kuru rezult\u0101t\u0101 iesaist\u012bt\u0101 publika tiek inform\u0113ta par uz\u0146\u0113muma produktu un t\u0101 labaj\u0101m \u012bpa\u0161\u012bb\u0101m. Farm\u0101cijas nozare tom\u0113r ir sare\u017e\u0123\u012bta, t\u0101 tiek p\u0101rkl\u0101ta ar konfidencialit\u0101tes pl\u012bvuru un katra inform\u0101cija tiek \u012bpa\u0161i kontrol\u0113ta, ta\u010du farm\u0101cij\u0101 izmantotos inform\u0101cijas nodo\u0161anas pa\u0146\u0113mienus veiksm\u012bgi var izmantot un adapt\u0113t ikvienas nozares p\u0101rst\u0101vji.<\/p>\n\n\n\n Protams, katr\u0101 nozar\u0113, kur\u0101 veiksm\u012bgi tiek izmantota rekl\u0101ma, produkta atpaz\u012bstam\u012bba un t\u0101 p\u0101rdo\u0161ana jau a priori<\/em> ir nodro\u0161in\u0101ta ar augstiem r\u0101d\u012bt\u0101jiem. Ta\u010du produkti, kuru rekl\u0101ma ir aizliegta, prasa izdomu, ori\u0123in\u0101lu pieeju un \u012bpa\u0161i uzman\u012bgu attieksmi. Pie\u0146emot, ka sabiedrisk\u0101s attiec\u012bbas ir svar\u012bgs posms \u0161\u0101du produktu un sabiedr\u012bbas savstarp\u0113j\u0101 mijiedarb\u012bb\u0101, ir svar\u012bgi apzin\u0101ties, k\u0101di ir galvenie m\u0113r\u0137i un auditorija, kuru nepiecie\u0161ams sasniegt. M\u0101rketings, t\u0101 strat\u0113\u0123ija un sabiedrisk\u0101s attiec\u012bbas vienot\u0101 kombin\u0101cij\u0101 ir visefekt\u012bv\u0101kais veids, k\u0101 pan\u0101kt nepiecie\u0161amo, virzot ne tikai produktu pre\u010du z\u012bmju noieta veicin\u0101\u0161anu, bet uz\u0146\u0113muma brenda un reput\u0101cijas stabiliz\u0113\u0161anu. Vissvar\u012bg\u0101kais, lai izv\u0113l\u0113t\u0101s metodes b\u016btu saska\u0146\u0101 ar nozares \u0113tiskaj\u0101m v\u0113rt\u012bb\u0101m, un tad t\u0101s b\u016bs efekt\u012bv\u0101kais risin\u0101jums rekl\u0101mas aizlieguma probl\u0113mai.<\/p>\n","protected":false},"excerpt":{"rendered":" Rekl\u0101mas, m\u0101rketings un sabiedrisk\u0101s attiec\u012bbas ir jebkura liela uz\u0146\u0113muma pamat\u0101, lai populariz\u0113tu un padar\u012btu atpaz\u012bstamu ne tikai uz\u0146\u0113mumu, bet ar\u012b t\u0101 pied\u0101v\u0101tos produktus. Bet ko…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-241","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=241"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/241\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Ta\u010du rekl\u0101mas aizliegums \u0161\u0101da veida produktiem padara inform\u0101cijas snieg\u0161anu sabiedr\u012bbai apgr\u016btino\u0161u. No vienas puses, ir pareizi aizliegt \u0161\u0101da veida prepar\u0101tus populariz\u0113t ar rekl\u0101mas starpniec\u012bbu, jo tas ir produkts, kas paredz\u0113ts noteiktai auditorijai ar konkr\u0113ti noteiktu m\u0113r\u0137i un, lietots neviet\u0101, var b\u016bt b\u012bstams. Tom\u0113r svar\u012bgi ir ar\u012b tas, ka sabiedr\u012bbai ir nepiecie\u0161ama inform\u0101cija par to, ko vi\u0146iem pied\u0101v\u0101 un k\u0101dus prepar\u0101tus, medikamentus iesaka \u0101rsti un farmaceiti. Rekl\u0101mas izmanto\u0161ana recep\u0161u medikamentiem pal\u012bdz\u0113tu apzi\u0146ot un inform\u0113t sabiedr\u012bbu par tai svar\u012bgiem jaut\u0101jumiem un sniegtu izpratni par to, kas ir tas, ko vi\u0146i lieto savas vesel\u012bbas lab\u0101.<\/p>\n\n\n\n